Effect of Lenalidomide Exposure on Response and Outcomes in Patients with Lower-Risk Non-Del(5Q) Myelodysplastic Syndromes (MDS). (April 2017) - Garcia-Manero, G.; Santini, V.; Almeida, A.; Fenaux, P.; Gattermann, N.; Ozawa, K.; Goldberg, S.L.; Weaver, J.; Sugrue, M.M.